Clinical Trial Update: A Study to Evaluate the Efficacy, Safety and Tolerability of CT327 in Atopic Dermatitis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the efficacy, safety and tolerability of CT327 in atopic dermatitis has completed, with the update summarizing the trial out…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• CT327

Snippet

Sponsor: Creabilis SA | Conditions: Atopic Dermatitis | Phase 2 | Status: COMPLETED